TMCnet News
Longeviti Launches ClearFit AI™, a Brain Ultrasound Interface (BUI) to Advance Platform Solutions for Neurological DisordersLongeviti Neuro Solutions, a neurotechnology company focused on advancing innovative solutions that unlock post-operative ultrasound access to the brain, today announced the launch of two strategic initiatives, ClearFit AI™, a Brain Ultrasound Interface (BUI). Together, these technologies create a persistent acoustic interface to the brain, enabling real-time bedside imaging and supporting future advances in AI-assisted neurosurgical care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260625051733/en/ 
ClearFit AI, a Brain Ultrasound Interface (BUI). The ClearFit AI™ platform combines:
This platform enables the Brain Ultrasound Interface (BUI) - a new category of post-operative neuro access that may reduce reliane on CT and MRI transport, integrate into existing neuro workflows, and position the implant site as a potential foundation for future applications currently under investigation. Operational and Economic Potential As healthcare systems continue to evaluate scalable and cost-conscious technologies, ultrasound-enabled imaging approaches may offer operational advantages in select care environments. Adjunct imaging technologies may contribute to:
Any future clinical, operational, or economic benefits will depend on regulatory review, validation activities, adoption patterns, and real-world implementation. Beyond the Implant For clinicians, BUI means the ability to assess the brain at the bedside - possibly reducing operational burdens such as scheduling imaging, transporting a post-operative patient, or waiting for results. ClearFit AI™ makes that possible by turning the implant site into a persistent sonolucent interface, with AI-assisted imaging optimization only available on Clarius Ultrasound units. For patients, that access may mean fewer trips to the scanner, less radiation exposure, and bedside visualization that may extend from the ICU into outpatient and recovery settings. "The mission was always in the name," said Jesse Christopher, CEO. "Longeviti exists to pursue scalable platform technologies that help create new possibilities for clinicians, researchers, and patients while supporting the broader goal of protecting cognitive function and improving quality of life." About Longeviti Neuro Solutions Longeviti Neuro Solutions is a US-based neurotechnology company pioneering the future of neurosurgical platform solutions. Our ClearFit AI, a Brain Ultrasound Interface (BUI) - an innovative solution that unlocks post-operative ultrasound access to the brain, giving clinicians unprecedented visibility into recovery. Longeviti Neuro Solutions designs and manufactures ultrasound-penetrable FDA-cleared implants that power the ClearFit AI™ platform - allowing bedside, AI-assisted ultrasound imaging, and visualization, and post-operative neurosurgical care.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260625051733/en/ |
